SITEONE THERAPEUTICS
SiteOne Therapeutics is a San Francisco-based company that develops novel therapeutics and diagnostics. They develop products safely, effectively, and efficiently treat acute and chronic pain without the limitations of existing therapies, such as NSAIDs and opioids. Their lead therapeutic candidates are highly selective inhibitors of a voltage-gated sodium ion channel, Naᵥ1.7, which plays a critical role in the generation and conduction of pain signals.
SITEONE THERAPEUTICS
Industry:
Biotechnology Health Diagnostics Medical Therapeutics
Founded:
2010-01-01
Address:
Bozeman, Montana, United States
Country:
United States
Website Url:
http://www.siteonetherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
+1 (406) 602-4558
Total Funding:
19.18 M USD
Technology used in webpage:
Google Font API Google Apps For Business Google Maps AJAX Libraries API GoDaddy DNS GStatic Google Static Content Google Maps API Squarespace Hosted
Current Advisors List
Board_member
Board_member
Board_member
2014-09-01
Board_member
Board_member
Board_member
Board_member
2018-01-01
Board_member
2014-07-01
Current Employees Featured
George Miljanich Co-Founder & Chief Scientific Officer @ SiteOne Therapeutics
Co-Founder & Chief Scientific Officer
John Mulcahy Vice President, Research @ SiteOne Therapeutics
Vice President, Research
2010-03-01
Stan Abel Chairman Of The Board Of Directors @ SiteOne Therapeutics
Chairman Of The Board Of Directors
2020-12-01
David C Yeomans Founder @ SiteOne Therapeutics
Founder
2010-08-01
Stan Abel CEO @ SiteOne Therapeutics
CEO
Founder
Investors List
Amgen
Amgen investment in Series B - SiteOne Therapeutics
Mission Bay Capital
Mission Bay Capital investment in Series B - SiteOne Therapeutics
NEXT Frontier Capital
NEXT Frontier Capital investment in Series B - SiteOne Therapeutics
Z Investments
Z Investments investment in Series B - SiteOne Therapeutics
BioBrit
BioBrit investment in Series B - SiteOne Therapeutics
Mission BioCapital
Mission BioCapital investment in Series B - SiteOne Therapeutics
2M Companies
2M Companies investment in Series B - SiteOne Therapeutics
Sears Capital Management
Sears Capital Management investment in Series B - SiteOne Therapeutics
Mission Bay Capital
Mission Bay Capital investment in Venture Round - SiteOne Therapeutics
Sears Capital Management
Sears Capital Management investment in Venture Round - SiteOne Therapeutics
Official Site Inspections
http://www.siteonetherapeutics.com
- Host name: 84.106.215.35.bc.googleusercontent.com
- IP address: 35.215.106.84
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "SiteOne Therapeutics"
SiteOne Therapeutics | Innovative Solutions for …
SiteOne Therapeutics, Inc. 280 Utah Ave., Suite 250 South San Francisco, CA 94080 +1 (650) 392-0419 info@site1therapeutics.comSee details»
SiteOne Therapeutics - Crunchbase Company Profile & Funding
SiteOne Therapeutics is a San Francisco-based company that develops novel therapeutics and diagnostics. They develop products safely, effectively, and efficiently treat acute and chronic …See details»
SiteOne Therapeutics Company Profile 2024: Valuation, …
SiteOne Therapeutics General Information Description. Developer of novel pain therapeutics intended to offer treatment for acute and chronic pain. The company's drugs provide treatment for neuropathic pain through novel pain …See details»
Siteone Therapeutics, Inc. in South San Francisco, CA - (650) 392 …
Siteone Therapeutics is located in South San Francisco, California. This organization primarily operates in the Proprietary Drug Products business / industry within the Chemicals and Allied …See details»
SiteOne Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
The National Institute on Drug Abuse through the NIH HEAL Initiative will fund development of SiteOne's selective NaV1.8 inhibitor for the treatment of pain SOUTH SAN FRANCISCO, …See details»
SiteOne Therapeutics - Craft
Jun 24, 2018 SiteOne Therapeutics has 5 employees across 2 locations and $17.78 m in total funding,. See insights on SiteOne Therapeutics including office locations, competitors, …See details»
SiteOne Therapeutics - Overview, News & Similar companies
May 12, 2021 www.siteonetherapeutics.com. Revenue $12.2 Million. Industry Business Services General Business Services . Recent News & Media. SiteOne Therapeutics Awarded up to …See details»
SiteOne Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore SiteOne Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 4 news, and 3 literature, Disease Domain:Nervous ...See details»
Siteone Therapeutics Company Profile -Sales, Contacts, …
Siteone Therapeutics is in the Biotechnical Research, Commercial industry within the Engineering, Accounting, Research, and Management Services sector and has been in …See details»
SiteOne Therapeutics, Inc. (SiteOne Therapeutics, Inc.) - 药物管线_ …
The National Institute on Drug Abuse through the NIH HEAL Initiative will fund development of SiteOne's selective NaV1.8 inhibitor for the treatment of pain SOUTH SAN FRANCISCO, …See details»
SiteOne Therapeutics - VentureRadar
Similar Companies: Algomedix USA Privately Held Algomedix is a leader in the development of novel Transient Receptor Potential (TRP) therapeutics to treat serious medical needs including …See details»
Siteone Therapeutics - highergov.com
Siteone Therapeutics (UEI ZKBYHMUQS291, CAGE 61AQ1) based in South San Francisco CA federal contracts, grants, registrations, vehicles, partnerships, and analysisSee details»
SiteOne Therapeutics Company Profile: Overview and Full News …
Siteonetherapeutics.com. Overview: SiteOne Therapeutics. SiteOne Therapeutics is a clinical-stage biopharmaceutical company based in Montana, focused on developing innovative …See details»
SiteOne Therapeutics, Inc. | Insights
May 25, 2023 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
SiteOne Therapeutics Awarded up to $15M Grant to Develop …
May 18, 2023 For more information, visit www.siteonetherapeutics.com. About the NIH HEAL Initiative. The Helping to End Addiction Long-term® Initiative, or NIH HEAL Initiative®, is an …See details»
Siteone Therapeutics, Inc. in San Francisco, CA - (607) 351-6082
Siteone Therapeutics, Inc. is in the Physical Therapist business. View competitors, revenue, employees, website and phone number.See details»
SiteOne Therapeutics Announces $1.73M Grant from NIH/NHLBI …
May 11, 2021 For more information, visit www.siteonetherapeutics.com. Media Contacts: David Schull Russo Partners, LLC [email protected] 858-717-2310. SOURCE SiteOne Therapeutics. …See details»
SiteOne Therapeutics Announces Collaboration and License
Jan 19, 2022 SOUTH SAN FRANCISCO, Calif., Jan. 19, 2022 /PRNewswire/ -- SiteOne Therapeutics, a clinical-stage biopharmaceutical company developing non-opioid treatments to …See details»
SiteOne Therapeutics Announces Collaboration and License …
Jan 19, 2022 For more information, visit www.siteonetherapeutics.com. Media Contacts: David Schull Russo Partners, LLC [email protected] 858-717-2310. SOURCE SiteOne Therapeutics.See details»
SiteOne Therapeutics Announces $1.73M Grant from NIH/NHLBI
SiteOne Therapeutics Announces $1.73M Grant from NIH/NHLBI ... - BioSpaceSee details»